Sapien 3 becomes first TAVI valve to be approved for low-risk patients in both Europe and the USA 7th November 2019
Ngày 11/11/2019 08:41 | Lượt xem: 122

Edwards Lifesciences has received the CE mark for its Sapien 3 transcatheter aortic valve implantation (TAVI) device to be used to manage aortic stenosis in low-risk patients. Both Edwards and Medtronic (with its CoreValve range) have FDA approval for their devices to be used for low-risk patients in the USA but, with this new CE mark approval, Edwards is the first TAVI company to have this indication in Europe.

According to a press release, this indication expansion in Europe follows on the publication earlier this year of data from the PARTNER 3 trial—an independently evaluated, randomised clinical trial that compared outcomes between TAVI and surgery in patients at low surgical risk. The trial found that TAVI with the Sapien 3 system achieved superiority, with a 46% reduction in the event rate for the primary endpoint of the trial; a composite of all-cause mortality, all stroke and rehospitalisation at one year. The data were published in the New England Journal of Medicine.

An additional study examining quality of life in the PARTNER 3 patients was published online in the Journal of the American College of Cardiology. The results of this study demonstrated significant early and sustained advantages for low-risk patients treated with the SAPIEN 3 valve. When the treatment strategies of TAVI and surgery were compared for low-risk patients, the TAVI patients improved more rapidly than surgery patients. Furthermore, this study showed, for the first time, patients treated with the SAPIEN 3 valve experienced a better quality of life even one year after the procedure.

Helge Möllmann (St Johannes Hospital, Dortmund, Germany) comments: “Now, all European patients diagnosed with aortic stenosis can be considered for TAVI with the Sapien 3 valve based on factors such as anatomical considerations or other individual needs rather than risk scores. This is particularly important for patients at low risk for surgery, whose only serious health issue may be aortic stenosis and who want to return to their lives more safely and quickly. Previously, their only treatment option was open-heart surgery, and this approval will expand access to the proven Sapien 3 valve.”

Source CardiovascularNews

Duc Tin Clinic

Print Chia sẽ qua facebook bài: Sapien 3 becomes first TAVI valve to be approved for low-risk patients in both Europe and the USA 7th November 2019 Chia sẽ qua google bài: Sapien 3 becomes first TAVI valve to be approved for low-risk patients in both Europe and the USA 7th November 2019 Chia sẽ qua twitter bài: Sapien 3 becomes first TAVI valve to be approved for low-risk patients in both Europe and the USA 7th November 2019 Chia sẽ qua MySpace bài: Sapien 3 becomes first TAVI valve to be approved for low-risk patients in both Europe and the USA 7th November 2019 Chia sẽ qua LinkedIn bài: Sapien 3 becomes first TAVI valve to be approved for low-risk patients in both Europe and the USA 7th November 2019 Chia sẽ qua stumbleupon bài: Sapien 3 becomes first TAVI valve to be approved for low-risk patients in both Europe and the USA 7th November 2019 Chia sẽ qua icio bài: Sapien 3 becomes first TAVI valve to be approved for low-risk patients in both Europe and the USA 7th November 2019 Chia sẽ qua digg bài: Sapien 3 becomes first TAVI valve to be approved for low-risk patients in both Europe and the USA 7th November 2019 Chia sẽ qua yahoo bài: Sapien 3 becomes first TAVI valve to be approved for low-risk patients in both Europe and the USA 7th November 2019 Chia sẽ qua yahoo bài: Sapien 3 becomes first TAVI valve to be approved for low-risk patients in both Europe and the USA 7th November 2019 Chia sẽ qua yahoo bài: Sapien 3 becomes first TAVI valve to be approved for low-risk patients in both Europe and the USA 7th November 2019 Chia sẽ qua yahoo bài: Sapien 3 becomes first TAVI valve to be approved for low-risk patients in both Europe and the USA 7th November 2019

Tin tức liên quan

CUSTOMER REVIEWS

  • I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

    I sincerely thank you !. Tel: 0938303275

  • Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

    Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

  • As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

  • The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

  • I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search
Customer support

    Phone: (028) 3981 2678
    Mobile: 0903 839 878 - 0909 384 389

TOP